CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Novel oncolytic Sendai viruses (SeV) for the virotherapeutic treatment of HCC
DOI 10.1055/s-0031-1296020
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Zimmermann, S Armeanu-Ebinger, S Bossow, J Lampe, I Smirnow, S Lange, TS Weiss, W Neubert, NP Malek, UM Lauer, M Bitzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: So far, most hepatocellular carcinomas (HCC) cannot be cured efficiently. Thus, virotherapy provides a great potential, especially when broad resistances to chemotherapeutic compounds exist. The resistance-breaking mechanism of virotherapeutics is based on selective replication of oncolytic viruses in tumor cells leading to a highly efficient oncolysis. Naturally, murine parainfluenza virus type I (Sen…
Zitieren
Zitierempfehlung
M Zimmermann, S Armeanu-Ebinger, S Bossow, J Lampe, I Smirnow, S Lange, TS Weiss, W Neubert, NP Malek, UM Lauer, M Bitzer (2012) Novel oncolytic Sendai viruses (SeV) for the virotherapeutic treatment of HCC. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1296020
Mit CareLit weiterarbeiten